baber/WOPTO huggingface dataset:
Patent NZ-572265-A (NZ)
Title: Polymeric fiber insulation batts for residential and commercial construction applications
Inventor: DEBLANDER JEAN-PHILIPPE
IPC: D04H13/00
Filed: 2007-04-26
Abstract: Disclosed is a compressible polyester fiber thermal insulation batt formed of entangled and meltbonded polyester fibers, the polyester fibers including from 55-85% by weight of at least one staple fiber and from 15-45% by weight of at least one binder fiber, wherein the average fiber diameter is from 7.0 to 20.5 microns and at least 55% by weight of the fibers are crimped, wherein the insulation batt (A) has an uncompressed bulk density of from 5 to 15 kg/m3, (B) exhibits a lambda value of from 30 to 50 mW/m-K, (C) exhibits a lambda*density value of from 250-550 when lambda is expressed in units of mW/m-K and density is expressed in units of kg/m3, (D) has an uncompressed thickness of from 25-300 mm and E) exhibits a tensile stress at break of at least 4 KPa in at least one of the machine and cross-machine directions. These batts can be made by forming a web of the fibers, and calibrating and heat-setting the web, and are suitable for building thermal insulating applications. The web can be formed using pneumatic or mechanical carding processes. In some processes, the batt can be made by forming a stack of multiple plies of the web and calibrating and heat-setting the stack.
Patent NZ-575871-A (NZ)
Title: Process for producing aqueous chlorous acid solution for use as disinfectant
Inventor: GODA HISATAKA
IPC: A01N25/02
Filed: 2007-08-28
Abstract: Disclosed herein is a process for producing an aqueous chlorous acid solution in which chlorous acid, which is safe for the human body, is easy to handle, and generates less chlorine dioxide, is yielded and used as a disinfectant for a pretreatment in food processing. Sulfuric acid of an aqueous solution thereof is added to an aqueous sodium chlorate solution in such an amount and concentration that the pH of the aqueous solution can be kept at 2.3-3.4 thereby generating chloric acid. Furthermore, hydrogen peroxide is added to the chloric acid in an amount which is equal to or larger than the amount necessary for a reduction redaction to yield chlorous acid. Any one of inorganic and organic acids and salts or a combination thereof can be further added to the aqueous solution containing chlorous acid to adjust the pH in the range of 3.2-7.0.
Patent NZ-577154-A (NZ)
Title: Silicone based tube for transporting malodoriforous matter from the human body
Inventor: TSAI MINGLIANG LAWRENCE
IPC: A61F5/44
Filed: 2007-10-24
Abstract: A tubular bowel management assembly for carrying malodoriforous or faecal matter from the rectum, the tubular bowel management assembly comprising a silicone based tube with one end insertable into and retainable within the rectum using an inflatable anal bulb, the tube extending externally from the rectum for conveying waste matter from the body to a collection container or bag. A tubular sleeve member comprising a flexible film odour barrier material of one or multiple layers with an oxygen transmission rate (OTR) no more than 1,000 cc/m2/day at 23°C, with the sleeve fitted and fastened either inside or outside the silicone tube using adhesive, heat, pressure or mechanical friction fit. The sleeve member material is selected from poly(vinylidene chloride) (PVDC); poly(vinyl alcohol) (PVOH); an ethylene vinyl alcohol copolymer (EVOH); a polyamide (nylon) or co-polyamide or polyamide blends selected from PA-6, PA-6,6, PA-11, and PA-12, amorphous polyamides, MXD6 polyamide; a polyester (PET); a polyester elastomer; glycol-modified polyester (PETG); a polyester or co-polyester blend; poly(acrylonitrile) (PAN); polyurethane (PUR); polyvinyl chloride (PVC); polychlorotrifluoro ethylene (PCTFE); styrene-acrylonitrile copolymers; acrylonitrilebutadiene- styrene terpolymers; poly( methyl methacrylate); styrene-butadiene copolymers.
Patent NZ-577219-A (NZ)
Title: Bicyclic compounds and use as antidiabetics
Inventor: FANG JING
IPC: C07D211/24
Filed: 2007-12-05
Abstract: Disclosed is a compound containing at least three cyclic rings of formula (I) wherein ring C is piperidine rings A and B are six-membered aromatic ring containing between 0 to 2 nitrogen atoms and the other substituents are as disclosed in the description. The compounds are useful for treating metabolic disorders or conditions such as diabetes and obesity. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the used of a compound of formula (I) in the manufacture of a medicament for use in treating prophylaxis of metabolic disorders or conditions such as diabetes and obesity. Further disclosed is the process for making a pharmaceutical composition comprising a compound of formula (I).
Patent NZ-577939-A (NZ)
Title: Compounds and compositions as channel activating protease inhibitors
Inventor: TULLY DAVID C
IPC: A61K31/401
Filed: 2007-11-21
Abstract: Disclosed is a compound of formula (1), wherein the substituents are as defined in the specification. The compounds are channel activating protease (CAP) inhibitors useful in the treatment of diseases.
Patent NZ-579631-A (NZ)
Title: Air control regulator for combustion chamber
Inventor: KENDALL MARK W
IPC: F23L1/00
Filed: 2008-04-11
Abstract: A firebox air control regulator 1 comprises a hollow body 4 with an inlet and an outlet and forming a channel for air to flow through the body 4, and a disc 43 located within the body 4 and movable along a first support rod 40 attached to the body 4. The outlet is pneumatically connected to an inlet to a firebox. The disc 43 is situated to provide resistance to the airflow. The body 4 comprises an inner surface 10 configured to form the airflow into air currents as air is drawn through the body 4 and around the disc 43, where the inner surface 10 provides an air passage that varies in size as the disc 43 moves along the first support rod 40. The movement of the disc 43 is limited by upper and lower stop members. The disk is held by gravity against the lower stop member 42 when air is not flowing through the body 4. The disc 43 moves along the first support rod 40 toward the upper stop member in response to the airflow such that the volume of air passing through the body 4 is automatically regulated by the movement of the disc 43 within the body 4. A lower portion 20 of the inner surface 10 of the body 4 comprises an ovaloid opening 50 that is larger than the circumference of the disc 43. The perimeter of the ovaloid opening 50 is formed from a plurality of intermittently spaced, arc shaped depressions and scalloped edges 49. This allows the formation of air columns in use so that the disc 43 is balanced by the incoming air with minimal wobble and the incoming air flow can be directly controlled.
Patent NZ-581164-A (NZ)
Title: Arylamide pyrimidone compounds
Inventor: LOCHEAD ALISTAIR
IPC: A61K31/495
Filed: 2008-05-14
Abstract: Disclosed is a pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof e.g. 4-chloro-2-methoxy-N-[2-(1-methyl-6-oxo-1,6-dihydro-[4,4']bipyrimidinyl-2-yl)ethyl]-benzamide wherein X represents two hydrogen atoms, a sulphur atom, an oxygen atom or an alkyl group and a hydrogen atom; Z represents a bond, an oxygen atom, a nitrogen atom substituted by a hydrogen atom or an alkyl group, a sulphur atom, a methylene; R1 represents a 2, 4 or 5-pyrimidine ring or a 4-pyridine ring; R3 represents a hydrogen atom, an alkyl group or a halogen atom; R4 represents a hydrogen atom or an alkyl group; R5 represents a hydrogen atom or an alkyl group; R6 represents a hydrogen atom or a C1-6 alkyl group; R7 represents a hydrogen atom or an alkyl group; n represents 0 to 3, and m represents 1, in the form of a free base or of an addition salt with an acid for treating Alzheimer's disease, Parkinson's disease, tauopathies, vascular dementia; acute stroke, traumatic injuries; cerebrovascular accidents, brain cord trauma, spinal cord trauma; peripheral neuropathies; retinopathies or glaucoma, diabetes; obesity, manic depressive illness; schizophrenia; alopecia; cancers; parenchymal renal diseases, malaria and Pemphigus vulgaris.
Patent NZ-586398-A (NZ)
Title: Hollow pest control station using pheromone and contact pesticide
Inventor: BOLIN DAVID G
IPC: A01M1/20
Filed: 2009-01-23
Abstract: An apparatus for pest control. The apparatus comprises a hollow station (250) in the form of an angulated tube including two downwardly-facing entrances (260, 265) for the pests to be controlled; a pheromone (165) of a pest to be controlled; and a contact pesticide (165) for the pests to be controlled, the contact pesticide being provided inside the hollow station. The hollow station is designed to prevent the pests from remaining within the hollow station without expenditure of energy.
Patent NZ-586867-A (NZ)
Title: Crystalline 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid monohydrochloride hemihydrate
Inventor: WERTHMANN ULRIKE
IPC: A61K31/404
Filed: 2009-01-22
Abstract: Disclosed is crystalline 4-[(Z)-[[4-[(dimethylamino)methyl]phenyl]amino](6-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-benzenepropanoic acid monohydrochloride hemihydrate characterised by a melting point of 285 ±5°C (as determined by differential scanning calorimetry at a heating rate of 10°C/min) and having the characteristic values d = 6.81 Å, 5.17 Å, 4.92 Å, 4.00 Å, 3.92 Å and 3.16 Å as determined by X-Ray powder diffraction. Further disclosed is a pharmaceutical composition which comprises the above compound in crystalline form and one or more inert carriers and/or diluents. .
Patent NZ-589862-A (NZ)
Title: Connector for connecting construction elements either vertically or horizontally
Inventor: TEDESCO DOMINIC
IPC: E04B1/24
Filed: 2009-04-29
Abstract: 589862 Disclosed is a connector system for connecting construction modules (120) in a substantially horizontal and/or substantially vertical manner. The connector system has a base with a perimeter and a first and a second side. The connector has a housing mounted on either the first or second side of the base. The housing has at least four angular faces which are either perpendicular or parallel to one another. The four faces have chamfered edges. The connector has a passageway which extends through the base and the housing. The four faces on the housing are capable of connecting construction modules in a substantially horizontal or vertical manner. The housing is substantially frustoconical in shape.
Patent NZ-597106-A (NZ)
Title: Ophthalmic compositions comprising carnitine and methods for treating eyes
Inventor: CHANG-LIN JOAN-EN
IPC: A61K9/08
Filed: 2005-11-14
Abstract: 597106 Disclosed is a topical ophthalmic composition for the treatment of dry eye comprising: an aqueous carrier; glycerol; carnitine, its isomers or suitable salts thereof; and an ionically charged polymeric material selected from the group consisting of carboxymethyl cellulose and mixtures of carboxymethyl cellulose compounds. Also disclosed is the use of the composition for the manufacture of a medicament for treating dry eye.
Patent NZ-600706-A (NZ)
Title: Method for producing phosphates and compounds containing phosphates, in particular alkaline-earth phosphates, alkaline-earth silicophosphates or alkaline-earth oxides
Inventor: KLOSE SIEGFRIED
IPC: C01B25/222
Filed: 2009-12-09
Abstract: Disclosed herein is a method for producing phosphates and/or compounds containing phosphates, in particular alkaline-earth phosphates, alkaline-earth silicophosphates, and alkaline-earth oxides, comprising the following steps: (a) heating bones and/or fish bones or a composition of said components in a pyrolysis process in the absence of oxygen and under reductive conditions at temperatures between 500 and 1100 °C, wherein among other things high-energy gases, vapors, and carbon are produced, (b) subsequently combusting the carbon produced in step (a) under oxidative conditions in an oxidation step, wherein an inorganic radical of alkaline-earth carbonates, alkaline-earth oxides, and alkaline-earth phosphates is produced.
Patent NZ-601543-A (NZ)
Title: Mutant forms of streptolysin o
Inventor: BENSI GIULIANO
IPC: A61K38/17
Filed: 2008-12-18
Abstract: 601543 Disclosed is a mutant streptolysin O (SLO) protein comprising amino acid deletion at amino acid position A248 of a SLO protein numbered according to the sequence set forth in SEQ ID NO: 1, wherein the haemolytic activity of the mutant SLO protein is reduced by at least 50% relative to wild-type SLO.
Patent NZ-607295-A (NZ)
Title: Emulsions for removal and prevention of deposits
Inventor: BIERGANNS PATRIC
IPC: C09K23/38
Filed: 2011-08-12
Abstract: This disclosure relates to an aqueous cleansing emulsion comprising of a hydrophobic component H1, a hydrophobic component H2, an emulsifier having a HLB value of 4 ± 2, an emulsifier E having a HLB value of 9 ± 2 and optionally an emulsifier E having an HLB value of 16 ± 4. H1 is selected from one of the following categories: aliphatic C10- or C15-terpene hydrocarbons; aliphatic C10- or C15-terpenoids; aliphatic C15- – C40-hydrocarbons and C6- – C30-carboxylic acid C1- – C30-alkyl esters. H2 is selected from one of the following categories: aliphatic C20- – C40-hydrocarbons; C6- – C30-carboxylic acid C1- – C30-alkyl esters; aliphatic C6- – C19-hydrocarbons; aromatic C10- or C15-terpenoids; aliphatic or aromatic C20-, C25-, C30- or C35-terpenoids; silicon oils and essential animal or vegetable oils. H1 and H2 are cannot both be aliphatic hydrocarbons or aliphatic terpenoids. The use of these emulsions in preventing deposits on water-bearing systems, such as those found in paper manufacture (Figure 1) is also covered by this disclosure, as well as methods to use these emulsions.
Patent NZ-612512-A (NZ)
Title: Use of chimeric antigen receptor-modified t cells to treat cancer
Inventor: JUNE CARL H
IPC: C07H21/04
Filed: 2011-12-09
Abstract: Disclosed is an isolated nucleic acid sequence encoding a chimeric antigen receptor (CAR), wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signaling region, and a CD3 zeta signaling domain, wherein the CD3 zeta signaling domain comprises the amino acid sequence of SEQ ID NO: 24; wherein the sequence is as disclosed in the specification.
Patent NZ-621481-A (NZ)
Title: Anti-tie2 antibodies uses thereof
Inventor: THURSTON GAVIN
IPC: C07K16/28
Filed: 2012-08-16
Abstract: Disclosed is an isolated antibody or antigen-binding fragment thereof that specifically binds human Tie2 and blocks the interaction between Tie2 and all four of Ang1, Ang2, Ang3 and Ang4, wherein the antibody or antigen-binding fragment interacts with amino acids 96-106 of SEQ ID NO:7, amino acids 139-152 of SEQ ID NO:7; and amino acids 166-175 of SEQ ID NO:7, as determined by hydrogen/deuterium exchange, and comprises the heavy and light chain complementarity determining regions (CDRs) of the antibody produced from a cell line deposited with the American Type Culture Collection under accession number PTA-12295. Also disclosed is the use of the above-described antibody or antigen-binding fragment thereof in the manufacture of a medicament for inhibiting the growth of a tumour in a patient.
Patent NZ-625133-A (NZ)
Title: Pallet
Inventor: DUNN MATTHEW
IPC: B65D19/40
Filed: 2012-12-07
Abstract: A stackable pallet (10) for use in transportation of goods and for stacking in a rotated stacking configuration with at least one second substantially same stackable pallet. The first-mentioned stackable pallet (10) includes a substantially planar body (12) having an upper face (14) and a lower face (16), a plurality of substantially parallel elongate support members (18) depending from the lower face (16) and a plurality of substantially parallel elongate slots (20), each slot open to at least the upper face (14). The stackable pallets may be stacked in a non-rotated configuration so that each pallet is stacked so that the support members (18) align with the elongate support members of the pallet below. The stackable pallets may be stacked in a rotated configuration so that each pallet is stacked so that the support members (18) align with the slots (20) of the pallet below. In the rotated configuration the pallets contain a small gap between adjacent stacked pallets so that the stack is compact. In the non-rotated configuration a larger gap is formed between pallets so that the forks of a forklift truck may pass between adjacent pallets.
Patent NZ-627041-A (NZ)
Title: Methods of forming 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol esters and methods of using the same
Inventor: OPPENHEIMER JOSSIAN
IPC: C07F5/02
Filed: 2012-12-20
Abstract: The disclosure relates to a method of using 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol ester comprise reacting the ester with a Suzuki’s coupling reactant in a medium consisting essentially of a palladium catalyst, a ligand, a base and at least one solvent to produce 6 (4-chloro-2-fluoro-3-substituted phenyl) 4 aminopicolinates. The disclosure also relates to a method of forming a 4-chloro-2-fluoro-3-substituted-phenylboronic acid pinacol ester, comprising: contacting a 1-chloro-3-fluoro-2-substituted benzene with an alkyl lithium to form a lithiated 1-chloro-3-fluoro-2-substituted benzene; contacting the lithiated 1-chloro-3-fluoro-2-substituted benzene with an electrophilic boronic acid derivative to form a 4-chloro-2-fluoro-3-substituted-phenylboronate; reacting the 4-chloro-2-fluoro-3-substituted-phenylboronate with an aqueous base to form a (4-chloro-2-fluoro-3-substituted-phenyl)trihydroxyborate; reacting the (4-chloro-2-fluoro-3-substituted-phenyl)trihydroxyborate with an acid to form a 4-chloro-2-fluoro-3-substituted-phenylboronic acid; and reacting the 4-chloro-2-fluoro-3-substituted-phenylboronic acid with 2,3-dimethyl-2,3-butanediol.
Patent NZ-628831-A (NZ)
Title: A method of manufacturing d-galactose for use of the production of d-tagatose from whey permeate or dried whey permeate
Inventor: SEONG BO KIM
IPC: C12P19/02
Filed: 2013-05-23
Abstract: Disclosed herein is a method for producing galactose from whey permeate liquid or whey permeate powder solution, the method comprising: a step of removing a solid precipitate from the whey permeate liquid or the solution of whey permeate powder; a step of removing protein from the whey permeate liquid or the solution of whey permeate powder from which the solid precipitate was removed; and a step of removing ash or salt or both from the whey permeate liquid or the solution of whey permeate powder from which the protein was removed. The disclosure also relates to a method for producing tagatose, wherein the method comprises a step of obtaining tagatose by isomerisation of the galactose produced by means of the abovementioned method
Patent NZ-700199-A (NZ)
Title: Epsilon toxin epitopes from clostridium perfringens with reduced toxicity
Inventor: TITBALL RICHARD W
IPC: C07K14/33
Filed: 2013-03-28
Abstract: There is provided an epsilon toxin epitope polypeptide comprising a sequence of at least 10 contiguous amino acids from SEQ ID NO:3, the sequence comprising a mutation of at least one tyrosine residue compared to the equivalent sequence in SEQ ID NO:3, the polypeptide being capable of binding an antibody which binds to SEQ ID NO:5 and having reduced toxicity compared with the toxicity of SEQ ID NO:5. The polypeptide is useful in a method of vaccinating a subject against developing a disease caused by Clostridium perfringens and/or caused by (or associated with the presence of) active epsilon toxin.
Patent NZ-710354-A (NZ)
Title: Soup preparation
Inventor: CRAIG BIRCHALL
IPC: B67D3/00
Filed: 2014-04-24
Abstract: A soup merchandiser includes a lidded warming kettle 15 that holds the soup and from which the soup can be dispensed out of a tap or faucet 15c without allowing evaporation of the liquid from the soup and a cover 17 that can be placed over the kettle to cover and embrace the kettle without touching the kettle but which allows the customer access 17d to the tap to allow the soup to be dispensed from the kettle. The cover prevents the customer from touching the hot kettle and contributes to the aesthetic appearance of the merchandiser.
Patent NZ-739679-A (NZ)
Title: Cholecalciferol sulfate salts and their use for the treatment of vitamin d deficiency
Inventor: SALAMI OYEWOLE
IPC: A61P43/00
Filed: 2016-07-12
Abstract: Pharmaceutically acceptable cholecalciferol sulfate salts are used for combating vitamin D3deficiency. The invention also relates to cholecalciferol sulfate salts and to pharmaceutical compositions of the pharmaceutically acceptable cholecalciferol sulfate salts.
Patent NZ-739943-A (NZ)
Title: Device to aid in arterial microvascular anastomosis
Inventor: PLOTT JEFFREY
IPC: A61B17/11
Filed: 2016-09-02
Abstract: An everter device to facilitate preparation of ends of arterial segments for end-to-end microvascular anastomosis. The device includes structure that provides sufficient support to prevent unwanted buckling of arterial tissue. The everter device offsets the tendency of the arterial tissue wall to recover its natural shape and fall off securement posts or pins of a coupler ring. The structure may be in the form of an intraluminal catheter balloon. Alternately, the structure may be in the form of a plunger. Alternately, the structure may be in the form of a radially expanding member provided on a shaft. The device further has a contoured surface on an everter end to evert a free end of arterial tissue over a coupler ring, and to cause the posts or pins of the coupler ring to pierce through the everted arterial tissue. The everter end is provided with one or more openings therein, such as a circumferential slot, to receive the posts or pins of the coupler ring.
Patent NZ-759944-A (NZ)
Title: Neoantigen vaccine composition for treatment of cancer
Inventor: NICOSIA ALFREDO
IPC: A61K39/385
Filed: 2018-07-12
Abstract: The present invention provides a polypeptide comprising at least four different tumor- specific neo-antigens fused to, at least one T cell enhancer amino acid sequence, a nucleic acid sequence encoding such polypeptide, a vector comprising such nucleic acid sequence and a collection of vectors comprising such vectors. Further provided are compositions of matter comprising in admixture or separately a vaccine comprising the polypeptide, the nucleic acid sequence the vector or the collection of vectors of the invention and at least one modulator of a checkpoint molecule or another type of immunomodulator for use in treating cancer.
Patent NZ-763060-A (NZ)
Title: Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia
Inventor: PELCMAN BENJAMIN
IPC: C07C215/30
Filed: 2018-09-13
Abstract: There is herein provided a compound of formula (I). The compounds are β2-adrenergic receptor agonists and are useful in the treatment of hyperglycaemia.
Patent NZ-764564-A (NZ)
Title: Methods of treating and preventing staphylococcus aureus infections and associated conditions
Inventor: TORRES VICTOR
IPC: A61K38/16
Filed: 2012-06-19
Abstract: Disclosed is a composition comprising a therapeutically effective amount of an isolated LukE protein or polypeptide thereof, an isolated LukD protein or polypeptide thereof, or a combination thereof, and a pharmaceutically acceptable carrier.